At a glance
ClinicalIndex Comparison RecordN/ACompleted· 45 enrolled
Drug / intervention
MyVoice:Rheum +1 moreother
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
A Pilot Study of the MyVoice:Rheum Decision Aid to Address the Reproductive Health Needs of Women With Rheumatic Diseases
In Brief
A clinical study evaluating MyVoice:Rheum and Pamphlet for Rheumatic Diseases and 2 related conditions. Completed, enrolled 45 participants across 2 sites.
Detailed Summary
This is a pilot trial to assess feasibility and acceptability of MyVoice:Rheum vs. a patient pamphlet among female patients ages 18-44 (n=40) who receive rheumatology care. • Hypothesis: MyVoice:Rheum will be feasible and acceptable to patients who receive rheumatology care.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States
Timeline
N/ACompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartJul 2021
Primary CompletionDec 2022
Study CompletionMar 2023
TodayJul 2026
First PostedMay 10, 2021
Enrollment StartJul 29, 2021
Primary CompletionDec 31, 2022
Study CompletionMar 1, 2023
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 5.1 years ago
Interventions
MyVoice:Rheumother
Participants will be given access to MyVoice:Rheum, a web-based decision aid (DA).
Pamphletother
Participants in this arm will be given a copy of an existing patient pamphlet